Lucid Diagnostics Inc (LUCD)

$1.04 +0.02 (1.96%)
Market Cap 199.16M
Revenue (ttm) 4.71M
Net Income (ttm) -58.01M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,231.63%
Debt to Equity Ratio 2.19
Volume 914,100
Avg Vol 728,508
Day's Range N/A - N/A
Shares Out 195.25M
Stochastic %K 25%
Beta 1.10
Analysts Strong Sell
Price Target $4.10

Company Profile

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths t...

Industry: Medical Devices
Sector: Healthcare
Phone: 917 813 1828
Address:
360 Madison Avenue, 25th Floor, New York, United States
TheBearVsTheBull
TheBearVsTheBull May. 12 at 7:56 PM
$LUCD somebody made a bet on potential medicare coverage.
0 · Reply
Shabbaman
Shabbaman May. 12 at 7:45 PM
$LUCD Cmon !! our time is coming!!!Maybe it's now
0 · Reply
minnesotafarmcountry
minnesotafarmcountry May. 12 at 7:33 PM
$LUCD 187k on the bid?
1 · Reply
minnesotafarmcountry
minnesotafarmcountry May. 12 at 7:24 PM
$LUCD Ready … 👍🏻
1 · Reply
oaksapollo
oaksapollo May. 12 at 3:26 PM
$LUCD fwiw new job posted, registry operations https://recruitingbypaycor.com/career/CareerHome.action?clientId=8a7883c686c42298018704f3e3711ee7 Clearly they are preparing to scale up, and the registry will provide extremely valuable data that will facilitate reimbursement, support the sales team, and guide future iterations of the test.
0 · Reply
theDailyMatters
theDailyMatters May. 12 at 2:24 PM
$LUCD reported yesterday. https://fintel.io/so/us/lucd/wells-fargo-company-mn
1 · Reply
Investbythenumbers
Investbythenumbers May. 12 at 11:54 AM
$LUCD Stay positive — our time is coming! I know it’s tough watching the major indices hit new all-time highs day after day while our share price pulls back. But that frustration won’t last. Everything changes with the draft LCD. Hold strong. Better days are ahead.
1 · Reply
traderjoe2018
traderjoe2018 May. 11 at 10:43 PM
$PAVM it makes me feel so good inside to realize how much money I pissed away in this shitty stock. Management is absolutely useless. Just destroying the retail investors while they pad their pockets. I’m just hoping for some kind of bump so I can finally get out. I will never recoup what I have lost. I genuinely feel sorry for all of us long holders. $LUCD could help but I won’t hold my breath.
3 · Reply
oaksapollo
oaksapollo May. 11 at 8:49 PM
$LUCD short interest flat over the last month or so, consistent with the theme of utter boredom and lack of any meaningful activity. https://www.nasdaq.com/market-activity/stocks/lucd/short-interest
0 · Reply
oaksapollo
oaksapollo May. 11 at 7:38 PM
$LUCD
1 · Reply
Latest News on LUCD
PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026

May 1, 2026, 8:31 AM EDT - 11 days ago

PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026

PAVM

Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026

Apr 30, 2026, 8:31 AM EDT - 12 days ago

Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026

PAVM

Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock

Apr 24, 2026, 10:23 AM EDT - 18 days ago

Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock

PAVM

Lucid Diagnostics prices 18M shares at $1.00 in registered direct offering

2026-04-23T12:35:46.000Z - 19 days ago

Lucid Diagnostics prices 18M shares at $1.00 in registered direct offering

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock

Apr 23, 2026, 8:30 AM EDT - 19 days ago

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock

PAVM

Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference

Apr 9, 2026, 8:01 AM EDT - 4 weeks ago

Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference

PAVM

Lucid Diagnostics price target raised to $9 from $8.25 at Ascendiant

2026-04-09T10:47:11.000Z - 4 weeks ago

Lucid Diagnostics price target raised to $9 from $8.25 at Ascendiant

PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio

Apr 2, 2026, 8:01 AM EDT - 5 weeks ago

PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio

PAVM

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 30, 2026, 8:00 AM EDT - 6 weeks ago

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

PAVM

Lucid Diagnostics Earnings Call Transcript: Q4 2025

Mar 26, 2026, 8:30 AM EDT - 6 weeks ago

Lucid Diagnostics Earnings Call Transcript: Q4 2025

Lucid Diagnostics reports Q4 adjusted EPS (10c) vs. (19c) last year

2026-03-26T12:06:39.000Z - 6 weeks ago

Lucid Diagnostics reports Q4 adjusted EPS (10c) vs. (19c) last year

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 26, 2026, 8:00 AM EDT - 6 weeks ago

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

PAVM

PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026

Mar 16, 2026, 9:01 AM EDT - 2 months ago

PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026

PAVM

Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026

Mar 12, 2026, 9:01 AM EDT - 2 months ago

Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026

PAVM

PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities

Feb 4, 2026, 8:01 AM EST - 3 months ago

PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities

PAVM

Why Are PAVmed (PAVM) & Lucid Diagnostics (LUCD) Stocks Up Today?

2026-01-21T13:49:11.000Z - 3 months ago

Why Are PAVmed (PAVM) & Lucid Diagnostics (LUCD) Stocks Up Today?

PAVM

Lucid Diagnostics awarded U.S. Dept of Veterans Affairs contract for EsoGuard

2026-01-21T13:05:14.000Z - 3 months ago

Lucid Diagnostics awarded U.S. Dept of Veterans Affairs contract for EsoGuard

PAVM

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®

Jan 21, 2026, 8:00 AM EST - 3 months ago

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®

PAVM

Lucid Diagnostics price target raised to $8.25 from $8 at Ascendiant

2025-12-10T15:15:28.000Z - 5 months ago

Lucid Diagnostics price target raised to $8.25 from $8 at Ascendiant

Lucid Diagnostics’ esophageal precancer detection tools show efficacy in study

2025-12-09T13:16:38.000Z - 5 months ago

Lucid Diagnostics’ esophageal precancer detection tools show efficacy in study

PAVM

Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection

Dec 9, 2025, 8:01 AM EST - 5 months ago

Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection

PAVM

Lucid Diagnostics files $175M mixed securities shelf

2025-12-05T22:10:09.000Z - 5 months ago

Lucid Diagnostics files $175M mixed securities shelf

Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree

Nov 20, 2025, 8:15 AM EST - 6 months ago

Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree

PAVM

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Nov 13, 2025, 8:15 AM EST - 6 months ago

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

PAVM

PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results

Nov 13, 2025, 8:00 AM EST - 6 months ago

PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results

PAVM

Lucid Diagnostics Earnings Call Transcript: Q3 2025

Nov 12, 2025, 8:30 AM EST - 6 months ago

Lucid Diagnostics Earnings Call Transcript: Q3 2025

Lucid Diagnostics reports Q3 EPS (10c), consensus (9c)

2025-11-12T13:06:08.000Z - 6 months ago

Lucid Diagnostics reports Q3 EPS (10c), consensus (9c)

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 8:00 AM EST - 6 months ago

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results

PAVM

PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025

Oct 30, 2025, 8:01 AM EDT - 6 months ago

PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025

PAVM

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025

Oct 29, 2025, 8:01 AM EDT - 7 months ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025

PAVM

Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit

Oct 15, 2025, 8:01 AM EDT - 7 months ago

Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit

PAVM

Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors

Sep 25, 2025, 8:01 AM EDT - 8 months ago

Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors

Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs

Sep 16, 2025, 8:01 AM EDT - 8 months ago

Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs

PAVM

Lucid Diagnostics Announces Closing of Public Offering of Common Stock

Sep 11, 2025, 9:17 AM EDT - 8 months ago

Lucid Diagnostics Announces Closing of Public Offering of Common Stock

PAVM

Lucid Diagnostics 25M share Spot Secondary priced at $1.00

2025-09-10T12:35:44.000Z - 8 months ago

Lucid Diagnostics 25M share Spot Secondary priced at $1.00

Lucid Diagnostics Announces Pricing of Public Offering of Common Stock

Sep 10, 2025, 8:00 AM EDT - 8 months ago

Lucid Diagnostics Announces Pricing of Public Offering of Common Stock

PAVM

Lucid Diagnostics announces common stock offering, no amount given

2025-09-09T20:12:09.000Z - 8 months ago

Lucid Diagnostics announces common stock offering, no amount given

Lucid Diagnostics Announces Proposed Public Offering of Common Stock

Sep 9, 2025, 4:01 PM EDT - 8 months ago

Lucid Diagnostics Announces Proposed Public Offering of Common Stock

PAVM

Lucid Diagnostics Transcript: Status Update

Sep 8, 2025, 8:30 AM EDT - 8 months ago

Lucid Diagnostics Transcript: Status Update

Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025

Sep 5, 2025, 9:16 AM EDT - 8 months ago

Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025

PAVM

Lucid Diagnostics Transcript: Cantor Global Healthcare Conference 2025

Sep 5, 2025, 8:35 AM EDT - 8 months ago

Lucid Diagnostics Transcript: Cantor Global Healthcare Conference 2025

Lucid Diagnostics price target raised to $2.50 from $2 at BTIG

2025-09-05T11:15:12.000Z - 8 months ago

Lucid Diagnostics price target raised to $2.50 from $2 at BTIG

Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025

Aug 27, 2025, 8:00 AM EDT - 9 months ago

Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025

PAVM

PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology

Aug 26, 2025, 8:01 AM EDT - 9 months ago

PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology

PAVM

PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results

Aug 14, 2025, 8:00 AM EDT - 9 months ago

PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results

PAVM

Lucid Diagnostics Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 13, 2025, 2:30 PM EDT - 9 months ago

Lucid Diagnostics Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Lucid Diagnostics Earnings Call Transcript: Q2 2025

Aug 13, 2025, 8:30 AM EDT - 9 months ago

Lucid Diagnostics Earnings Call Transcript: Q2 2025

Lucid Diagnostics reports Q2 non-GAAP EPS (10c), consensus (10c)

2025-08-13T12:05:37.000Z - 9 months ago

Lucid Diagnostics reports Q2 non-GAAP EPS (10c), consensus (10c)

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 8:00 AM EDT - 9 months ago

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results

PAVM

Lucid Diagnostics to Participate in Upcoming Investor Conferences

Aug 5, 2025, 8:00 AM EDT - 10 months ago

Lucid Diagnostics to Participate in Upcoming Investor Conferences

PAVM

PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025

Jul 31, 2025, 8:01 AM EDT - 10 months ago

PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025

PAVM

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025

Jul 30, 2025, 8:01 AM EDT - 10 months ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025

PAVM

PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Jul 30, 2025, 8:00 AM EDT - 10 months ago

PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

PAVM

BTIG buyers of Lucid Diagnostics ahead of Medicare coverage

2025-07-28T17:55:17.000Z - 10 months ago

BTIG buyers of Lucid Diagnostics ahead of Medicare coverage

MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test

Jul 16, 2025, 7:31 AM EDT - 10 months ago

MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test

PAVM

Lucid Diagnostics management to meet virtually with BTIG

2025-06-30T16:00:43.000Z - 11 months ago

Lucid Diagnostics management to meet virtually with BTIG

Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test

Jun 18, 2025, 12:02 PM EDT - 11 months ago

Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test

PAVM

Lucid Diagnostics Transcript: AGM 2025

Jun 18, 2025, 11:00 AM EDT - 11 months ago

Lucid Diagnostics Transcript: AGM 2025

Lucid Diagnostics price target raised to $7.75 from $7.50 at Ascendiant

2025-06-06T09:40:18.000Z - 1 year ago

Lucid Diagnostics price target raised to $7.75 from $7.50 at Ascendiant

Lucid Diagnostics to join Russell 2000, Russell 3000 indexes

2025-05-27T11:35:23.000Z - 1 year ago

Lucid Diagnostics to join Russell 2000, Russell 3000 indexes

PAVM

Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes

May 27, 2025, 7:31 AM EDT - 1 year ago

Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes

PAVM

PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results

May 15, 2025, 8:01 AM EDT - 1 year ago

PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results

PAVM

Lucid Diagnostics Earnings Call Transcript: Q1 2025

May 14, 2025, 8:30 AM EDT - 1 year ago

Lucid Diagnostics Earnings Call Transcript: Q1 2025

Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results

May 14, 2025, 8:01 AM EDT - 1 year ago

Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results

PAVM

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

May 1, 2025, 8:31 AM EDT - 1 year ago

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

PAVM

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025

Apr 30, 2025, 8:31 AM EDT - 1 year ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025

PAVM

NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD

Apr 24, 2025, 8:01 AM EDT - 1 year ago

NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD

PAVM

Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

Apr 3, 2025, 9:00 AM EDT - 1 year ago

Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

PAVM

Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology

Mar 27, 2025, 8:01 AM EDT - 1 year ago

Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology

PAVM

Lucid Diagnostics Earnings Call Transcript: Q4 2024

Mar 24, 2025, 8:30 AM EDT - 1 year ago

Lucid Diagnostics Earnings Call Transcript: Q4 2024

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 24, 2025, 8:01 AM EDT - 1 year ago

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

PAVM

Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening

Mar 20, 2025, 8:31 AM EDT - 1 year ago

Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening

PAVM

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

Mar 18, 2025, 8:31 AM EDT - 1 year ago

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

PAVM

Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test

Mar 13, 2025, 7:36 AM EDT - 1 year ago

Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test

PAVM

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025

Mar 10, 2025, 9:01 AM EDT - 1 year ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025

PAVM

Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering

Mar 5, 2025, 4:45 PM EST - 1 year ago

Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering

PAVM

TheBearVsTheBull
TheBearVsTheBull May. 12 at 7:56 PM
$LUCD somebody made a bet on potential medicare coverage.
0 · Reply
Shabbaman
Shabbaman May. 12 at 7:45 PM
$LUCD Cmon !! our time is coming!!!Maybe it's now
0 · Reply
minnesotafarmcountry
minnesotafarmcountry May. 12 at 7:33 PM
$LUCD 187k on the bid?
1 · Reply
minnesotafarmcountry
minnesotafarmcountry May. 12 at 7:24 PM
$LUCD Ready … 👍🏻
1 · Reply
oaksapollo
oaksapollo May. 12 at 3:26 PM
$LUCD fwiw new job posted, registry operations https://recruitingbypaycor.com/career/CareerHome.action?clientId=8a7883c686c42298018704f3e3711ee7 Clearly they are preparing to scale up, and the registry will provide extremely valuable data that will facilitate reimbursement, support the sales team, and guide future iterations of the test.
0 · Reply
theDailyMatters
theDailyMatters May. 12 at 2:24 PM
$LUCD reported yesterday. https://fintel.io/so/us/lucd/wells-fargo-company-mn
1 · Reply
Investbythenumbers
Investbythenumbers May. 12 at 11:54 AM
$LUCD Stay positive — our time is coming! I know it’s tough watching the major indices hit new all-time highs day after day while our share price pulls back. But that frustration won’t last. Everything changes with the draft LCD. Hold strong. Better days are ahead.
1 · Reply
traderjoe2018
traderjoe2018 May. 11 at 10:43 PM
$PAVM it makes me feel so good inside to realize how much money I pissed away in this shitty stock. Management is absolutely useless. Just destroying the retail investors while they pad their pockets. I’m just hoping for some kind of bump so I can finally get out. I will never recoup what I have lost. I genuinely feel sorry for all of us long holders. $LUCD could help but I won’t hold my breath.
3 · Reply
oaksapollo
oaksapollo May. 11 at 8:49 PM
$LUCD short interest flat over the last month or so, consistent with the theme of utter boredom and lack of any meaningful activity. https://www.nasdaq.com/market-activity/stocks/lucd/short-interest
0 · Reply
oaksapollo
oaksapollo May. 11 at 7:38 PM
$LUCD
1 · Reply
dmscott2008
dmscott2008 May. 11 at 4:49 PM
$LUCD can this be our week please
1 · Reply
chuckjackson
chuckjackson May. 10 at 1:59 PM
$PAVM $LUCD
4 · Reply
oaksapollo
oaksapollo May. 10 at 3:27 AM
$LUCD k now do Lucid
0 · Reply
chuckjackson
chuckjackson May. 9 at 3:34 PM
$LUCD only 3 more trading days before we might get the draft lcd or we will be listening to Lishan give us an update of when to expect the draft. If I were to look at this with the glass half full, moidx has already communicated to lucd that they are releasing the draft. Pavm has recently (within the past week or so) changed their investor relations page to increase the number of shares to 11.88M which is an increase of about 4.61M shares. Pavm has indicated they will force the conversion of warrants into 4.61M shares if they receive the draft lcd. $PAVM
3 · Reply
JRINPHX
JRINPHX May. 8 at 8:42 PM
$LUCD 120,000 shares near the close. Was that a Buy or Sell?
1 · Reply
oaksapollo
oaksapollo May. 8 at 3:31 PM
$LUCD Still no agenda for this open meeting. It has to be posted 10 days in advance so sometime in the next 3 weeks. Something has to take this spot! I sure hope it's L39256.
1 · Reply
JRINPHX
JRINPHX May. 8 at 1:52 PM
$LUCD Shakin’ the trees for shares I see. Or, is it complete lack of investor interest?
1 · Reply
oaksapollo
oaksapollo May. 8 at 1:44 PM
$LUCD fintel has a new 1.6 million share position held by Russell Investments Group https://fintel.io/so/us/lucd Not really big news but the bar for news is getting lower and lower.
2 · Reply
DTLB411
DTLB411 May. 8 at 11:47 AM
$LUCD hire the Reimbursement team support! They’ll be working hard soon!
2 · Reply
DTLB411
DTLB411 May. 7 at 8:20 PM
$LUCD where’s Dave when I need him! (Not that I agree with him but sometimes I won’t be as bullish). I told myself I wouldn’t buy any more shares but I can’t seem to stop. $1.05 is too low based off retail panicking about NO news……
0 · Reply
tommyrulz
tommyrulz May. 7 at 4:17 PM
$LUCD we need Joe Rogan to call RFK JR 😎
1 · Reply
Elomee
Elomee May. 7 at 2:54 PM
$LUCD seems like it's settled in, i can't get my order to fill at 1.07
1 · Reply